Carmat SA (Germany) Today
| CXT Stock | EUR 1.05 0.07 6.25% |
Performance0 of 100
| Odds Of DistressOver 54
|
Carmat SA is trading at 1.05 as of the 25th of November 2024. This is a 6.25% down since the beginning of the trading day. The stock's lowest day price was 0.99. Carmat SA has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Carmat SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT EO operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. The company has 22.67 M outstanding shares. More on Carmat SA
Moving against Carmat Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Carmat Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Carmat SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Carmat SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Carmat SA (CXT) is traded on Frankfurt Exchange in Germany and employs 171 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 209.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carmat SA's market, we take the total number of its shares issued and multiply it by Carmat SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carmat SA classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 22.67 M outstanding shares.
Carmat SA has accumulated about 35.98 M in cash with (60.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Carmat SA Probability Of Bankruptcy
Ownership AllocationCarmat SA holds a total of 22.67 Million outstanding shares. Carmat SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Carmat Ownership Details
Carmat SA Risk Profiles
Although Carmat SA's alpha and beta are two of the key measurements used to evaluate Carmat SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.55 | |||
| Standard Deviation | 5.3 | |||
| Variance | 28.09 | |||
| Risk Adjusted Performance | (0.16) |
Carmat Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Carmat SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Carmat SA Corporate Management
Elected by the shareholders, the Carmat SA's board of directors comprises two types of representatives: Carmat SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carmat. The board's role is to monitor Carmat SA's management team and ensure that shareholders' interests are well served. Carmat SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carmat SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francesco Arecchi | Marketing Mang | Profile | |
| Petrus Jansen | Chief Officer | Profile | |
| Eric Richez | Sales Director | Profile | |
| Stephane Piat | CEO Director | Profile | |
| Raouia Bouyanzer | HR Director | Profile | |
| Pascale dArbonneau | CFO relations | Profile |
Other Information on Investing in Carmat Stock
Carmat SA financial ratios help investors to determine whether Carmat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carmat with respect to the benefits of owning Carmat SA security.